The 2021 US Patient Study of Asthma Medications

DUBLIN, July 11, 2022 /PRNewswire/ -- The "The 2021 US Patient Study of Asthma Medications" report has been added to ResearchAndMarkets.com's offering.

OTC meds are taking on a bigger role in asthma treatment and sufferers are reporting higher satisfaction levels with these OTCs than in the past. The 2021 Adult Patient Study of Asthma Medications is part of a continuing series of surveys designed to provide subscribers with invaluable insights into adult asthma sufferers' awareness, usage and attitudes toward prescription and non-prescription asthma medication.

Phase I - General Population Survey

• Incidence of diagnosed asthma among adults
• Report of asthma among other household members
• Take medications for asthma

Phase II - Survey Among Adult Asthmatics Taking Medication

• Asthma history, symptoms and triggers
• Severity of asthma
• Managing/treating asthma, including use of Rx and non-Rx medications, diet and role of physician
• Brand awareness and usage, including brand switching and loyalty
• Changing attitudes towards asthma

A market segmentation analysis was conducted to provide insights on how asthma medicators segment along attitudinal dimensions.

Electronic Deliverables

• Summary Volume - Written analysis in PowerPoint including Key Findings, Summary and Market Segmentation.
• Top-line Trends Volume - Trended top-line tables detailing findings from all questions.
• Excel Tabulations - All survey questions cross-tabulated by key demographics (see below for list of variables)

Key Topics Covered:

INTRODUCTION

METHODOLOGY

KEY FINDINGS

SUMMARY OF FINDINGS
Phase I: General Population Survey

• Incidence of Asthma & Treatment
• Diagnosed Asthma by Demographics
• Household Members With Asthma

Phase II: Survey of Adult Medicators
Section 1: Living With Asthma

• Severity of Asthma
• Severity of Asthma By Subgroups
• Persistence & Seasonality of Asthma
• Age When Asthma Was Diagnosed
• Asthma Interferes With Daily Activities
• Frequency of Asthma Symptoms
• Asthma Symptoms Considered Most Bothersome
• Asthma Related Emergency Room & Hospital Visits
• Asthma Triggers
• Attitudes About Living With Asthma

Section 2: Managing Asthma

• Information Sources for Asthma
• Type of Doctor Seen for Asthma
• Medication Usage
• Use of a Peak Flow Meter
• Use of Rescue Inhaler
• Refill of Rescue Inhaler & Number of Units
• Type of Inhaler Preferred
• Lifestyle Changes to Help Control Asthma
• Foods That Help Reduce Asthma Symptoms
• Foods & Ingredients Avoid to Lessen Asthma Symptoms
• Satisfaction With Aspects of Managing Asthma
• Self Assessment of Ability to Control Asthma
• Challenges in Controlling Asthma
• Concern About Cost of Asthma Treatment & Prevention
• Attitudes About Managing Asthma

Section 3: Asthma & Allergies

• Incidence of Allergies Among Medicators
• How Seasonal Allergies are Treated

Section 4: Rx Brand Awareness & Usage

• Awareness of Rx Asthma Medication Brands
• Advertising Awareness for Rx Asthma Medication Brands
• Rx Asthma Medication Brands Used
• Current Usage of Rx Asthma Medication Brands
• Requests for Rx Medication

Section 5: Rx Medication Usage Patterns

• Number & Frequency of Prescription Medications Taken
• Forms of Rx Medication Used
• Satisfaction With Rx Medication
• Switching to a New Prescription
• Brands Discontinued Versus Switched To
• Satisfaction With Current Prescription Regimen

Section 6: Non-Rx Medication Usage Patterns

• Details of Non-Rx Medication Usage
• Use of Non-Rx Medication Brands for Asthma
• Satisfaction With Effectiveness of Non-Rx Medication

Section 7: Impact of COVID-19

• Asthma Symptoms & Medication Change Since COVID-19 Outbreak
• Rating of Disruption of COVID-19
• Perception of How Long Until Country Will be Back to Normal

SEGMENTATION

For more information about this report visit https://www.researchandmarkets.com/r/irdkww

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]   

For E.S.T Office Hours Call +1-917-300-0470 
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets